Skip to content

Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software

Patient Reported Satisfaction With Contoura LASIK Utilizing the Phorcides Analytic Software

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05848817
Enrollment
50
Registered
2023-05-08
Start date
2023-05-19
Completion date
2024-08-15
Last updated
2025-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The objective is to determine the percentage of subjects satisfied (Completely Satisfied or Very Satisfied) with vision after Phorcides Planned Contoura LASIK.

Detailed description

This study is a single site, single-arm, prospective, observational study of subject satisfaction, after successful bilateral LASIK surgery. Subjects will be assessed pre-operatively, operatively and at 1 week, 1 month, and 3 months post-operatively. Clinical evaluations will include measurement of visual acuity, manifest refraction, and topography, aberrometry, and administration of the OSDI and PROWL questionnaires.

Interventions

DEVICEContoura LASIK

Subjects receiving Phorcides Planned Contoura LASIK

Sponsors

Sengi
CollaboratorINDUSTRY
Mann Eye Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to 39 Years

Inclusion criteria

Subjects are eligible for the study if they meet the following criteria: Note: Ocular criteria must be met in both eyes. * Appropriate candidate for uncomplicated bilateral LASIK surgery * Gender: Males and Females. * Age: 21 to 39 years of age. * Refractive error range - SE refractive errors up to 0.00 to -9.00 D with maximum cylinder up to 3.00 D and sphere ≤ -8.00 D. * If currently wearing contact lenses: * Soft CTL wearers discontinue for minimum 3 days * RGP CTL wearers discontinue for 1 month per decade of wear * Stable refraction (2 consecutive manifest refractions within 0.25 SE) * Stable K readings (2 consecutive K readings in 2 consecutive visits) * Residual bed thickness 250um or greater * Willing and able to comply with scheduled visits and other study procedures. * Pre-surgery BCDVA of 20/20 (0.00 logMAR) or better in each eye. If any of the following

Exclusion criteria

are applicable to the subject or either eye, the subject should not be enrolled in the study. * Subjects with history of previous ocular surgery. * Subjects with topographic evidence of keratoconus, or ectasia. * Subjects with autoimmune diseases. * Subjects who are pregnant or nursing. * Systemic disease likely to affect wound healing, such as diabetes and severe atopy. * Any ocular disease (including un-controlled dry eye) which in the investigator's opinion would affect the outcome of refractive surgery. The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial. Pregnancy has a known effect on the stability of refractions and visual acuity. As such, subjects who become pregnant during the study will not be discontinued but their data may be excluded from analyses of effectiveness.

Design outcomes

Primary

MeasureTime frameDescription
Subject Satisfaction3 Months PostoperativePercentage of subjects satisfied with vision after Phorcides Planned Contoura LASIK (answering Completely Satisfied or Very Satisfied on PROWL Questionnaire Question #1.

Secondary

MeasureTime frame
Number of Eyes With Post-op Spherical Equivalent Within +/- 0.50 D3 Months Postoperative

Other

MeasureTime frameDescription
PROWL Questionnaire3 Months PostoperativePROWL-SS can be used to assess satisfaction with vision and the existence, bothersomeness and impact on usual activities in the last 7 days of four visual symptoms - double images (8 items), glare (8 items), halos (8 items) and starbursts (8 items). Subjects select one of 6 responses for each question. Responses are scaled from 0 to 100, with 0 being a worse overall outcome and 100 being a better overall outcome for the existence, bothersomeness and impact on usual activities in the last 7 days of four visual symptoms - double images (8 items), glare (8 items), halos (8 items) and starbursts (8 items).
OSDI Score3 Months PostoperativeThe OSDI© is assessed on a scale of 0 to 100, with higher scores representing greater disability. The index demonstrates sensitivity and specificity in distinguishing between normal subjects and patients with dry eye disease. The OSDI© is a valid and reliable instrument for measuring dry eye disease (normal, mild to moderate, and severe) and effect on vision-related function.

Countries

United States

Participant flow

Participants by arm

ArmCount
Contoura LASIK
Subjects receiving Phorcides Planned Contoura LASIK. Contoura LASIK: Subjects receiving Phorcides Planned Contoura LASIK
50
Total50

Baseline characteristics

CharacteristicContoura LASIK
Age, Continuous29.3 years
STANDARD_DEVIATION 5
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
30 Participants
Sex: Female, Male
Male
20 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 50
other
Total, other adverse events
0 / 50
serious
Total, serious adverse events
0 / 50

Outcome results

Primary

Subject Satisfaction

Percentage of subjects satisfied with vision after Phorcides Planned Contoura LASIK (answering Completely Satisfied or Very Satisfied on PROWL Questionnaire Question #1.

Time frame: 3 Months Postoperative

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Contoura LASIKSubject Satisfaction50 Participants
Secondary

Number of Eyes With Post-op Spherical Equivalent Within +/- 0.50 D

Time frame: 3 Months Postoperative

ArmMeasureValue (COUNT_OF_UNITS)
Contoura LASIKNumber of Eyes With Post-op Spherical Equivalent Within +/- 0.50 D90 eyes
Other Pre-specified

OSDI Score

The OSDI© is assessed on a scale of 0 to 100, with higher scores representing greater disability. The index demonstrates sensitivity and specificity in distinguishing between normal subjects and patients with dry eye disease. The OSDI© is a valid and reliable instrument for measuring dry eye disease (normal, mild to moderate, and severe) and effect on vision-related function.

Time frame: 3 Months Postoperative

ArmMeasureValue (MEAN)Dispersion
Contoura LASIKOSDI Score7.5 score on a scale (0 to 100)Standard Deviation 6.7
Other Pre-specified

PROWL Questionnaire

PROWL-SS can be used to assess satisfaction with vision and the existence, bothersomeness and impact on usual activities in the last 7 days of four visual symptoms - double images (8 items), glare (8 items), halos (8 items) and starbursts (8 items). Subjects select one of 6 responses for each question. Responses are scaled from 0 to 100, with 0 being a worse overall outcome and 100 being a better overall outcome for the existence, bothersomeness and impact on usual activities in the last 7 days of four visual symptoms - double images (8 items), glare (8 items), halos (8 items) and starbursts (8 items).

Time frame: 3 Months Postoperative

ArmMeasureGroupValue (MEAN)Dispersion
Contoura LASIKPROWL QuestionnaireSatisfaction score94.8 score on a scale (0 to 100)Standard Deviation 8.9
Contoura LASIKPROWL QuestionnaireDouble image score99.4 score on a scale (0 to 100)Standard Deviation 4.6
Contoura LASIKPROWL QuestionnaireGlare score97.7 score on a scale (0 to 100)Standard Deviation 5.9
Contoura LASIKPROWL QuestionnaireHalo Score94.2 score on a scale (0 to 100)Standard Deviation 7.4
Contoura LASIKPROWL QuestionnaireStarburst score93.3 score on a scale (0 to 100)Standard Deviation 8.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026